Lv51
1280 积分 2023-12-22 加入
Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China
5小时前
已完结
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
2个月前
已完结
Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases
3个月前
已完结
Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO
5个月前
已完结
血脂异常医学营养管理专家共识
8个月前
已完结
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
8个月前
已完结
News from the NLA
8个月前
已关闭
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
9个月前
已完结
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
9个月前
已完结
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
11个月前
已完结
皖公网安备34019202002308
